» Articles » PMID: 37555467

Effects of 2-year Dietary and Physical Activity Intervention on Cognition in Children-a Nonrandomized Controlled Trial

Overview
Specialty Orthopedics
Date 2023 Aug 9
PMID 37555467
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: We investigated the effects of a combined dietary and PA intervention on cognition in children and whether changes in diet quality, PA, sedentary behavior (SB), and sedentary time (ST) are associated with changes in cognition.

Methods: We conducted a 2-year nonrandomized controlled trial in 504 children aged 6-9 years at baseline. The children were allocated to a combined dietary and PA intervention group (n = 237) or a control group (n = 160) without blinding.

Interventions: The children and their parents allocated to the intervention group had six dietary counseling sessions of 30-45 min and six PA counseling sessions of 30-45 min during the 2-year intervention period. The children were also encouraged to participate in after-school exercise clubs. Cognition was assessed by the Raven's Colored Progressive Matrices. We assessed dietary factors by 4 days food records and computed the Baltic Sea Diet Score (BSDS) as a measure of diet quality. PA and ST were assessed by a combined heart rate and body movement monitor, types of PA and SB by a questionnaire.

Results: The intervention had no effect on cognition. Increased BSDS and consumption of low-fat milk and decreased consumption of red meat and sausages were associated with improved cognition over 2 years. Increased organized sports, ST, and reading were positively, while unsupervised PA, computer use, and writing were negatively associated with cognition.

Conclusion: Combined dietary and PA intervention had no effect on cognition. Improved diet quality and increased organized sports and reading were associated with improved cognition.

Citing Articles

Eight-year diet and physical activity intervention affects serum metabolites during childhood and adolescence: A nonrandomized controlled trial.

Zarei I, Eloranta A, Klavus A, Vaisto J, Lehtonen M, Mikkonen S iScience. 2024; 27(7):110295.

PMID: 39055945 PMC: 11269805. DOI: 10.1016/j.isci.2024.110295.


A narrative review about cognitive impairment in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach.

Meroni M, Longo M, Paolini E, Dongiovanni P J Adv Res. 2024; 68:231-240.

PMID: 38369241 PMC: 11785580. DOI: 10.1016/j.jare.2024.02.007.